• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性和散发性乳腺癌中的微卫星不稳定性

Microsatellite instability in hereditary and sporadic breast cancers.

作者信息

Adem Camilo, Soderberg Cheryl L, Cunningham Julie M, Reynolds Carol, Sebo Thomas J, Thibodeau Stephen N, Hartmann Lynn C, Jenkins Robert B

机构信息

1Division of Laboratory Genetics, Mayo Clinic and Mayo Foundation, Rochester, MN, USA.

出版信息

Int J Cancer. 2003 Nov 20;107(4):580-2. doi: 10.1002/ijc.11442.

DOI:10.1002/ijc.11442
PMID:14520695
Abstract

Sporadic cancers and familial breast cancers are characterized by an increase in genetic instability. Little is known about whether mismatch repair defects accompany this genetic instability. We investigated invasive and/or in situ breast cancers from 30 women with deleterious BRCA1/2 mutations and unclassified variant BRCA1/2 alterations. Forty cases of sporadic breast cancers were also investigated, including 7 medullary carcinomas. Malignant and benign lesions were examined from all cases to better understand tumor progression. Automated immunohistochemistry, with antibodies directed against hMLH1 and hMSH2, was used to screen cases for possible mismatch repair defects. When loss of expression was noted, DNA ploidy was performed by cytomorphometry. DNA, after laser microdissection, was extracted from a majority of familial cases and their corresponding controls, and microsatellite instability analysis was performed. None of the familial or sporadic cases had loss of hMSH2 expression. All but one lesion, a DCIS arising in a deleterious BRCA2 mutation carrier, had loss of hMLH1 expression and a tetraploid profile by image cytomorphometry. There was no MSI in any explored lesions (n = 34), as determined by molecular analysis, including the DCIS with loss of hMLH1 expression. We conclude that DNA mismatch repair defects involving hMLH1 and hMSH2 underexpression are extremely rare events in sporadic and familial breast cancer. Mismatch repair gene mutations may be secondary random events in breast cancer progression.

摘要

散发性癌症和家族性乳腺癌的特征是基因不稳定性增加。关于错配修复缺陷是否伴随这种基因不稳定性,目前所知甚少。我们研究了30名携带有害BRCA1/2突变和未分类的BRCA1/2变异的女性的浸润性和/或原位乳腺癌。还研究了40例散发性乳腺癌,其中包括7例髓样癌。检查了所有病例的恶性和良性病变,以更好地了解肿瘤进展。使用针对hMLH1和hMSH2的抗体进行自动免疫组织化学分析,以筛查可能存在错配修复缺陷的病例。当发现表达缺失时,通过细胞形态计量学进行DNA倍体分析。在大多数家族性病例及其相应对照中,经过激光显微切割后提取DNA,并进行微卫星不稳定性分析。家族性或散发性病例中均未出现hMSH2表达缺失。除了一个病变(一名携带有害BRCA2突变的患者发生的导管原位癌)外,所有病变均出现hMLH1表达缺失,并通过图像细胞形态计量学显示为四倍体特征。通过分子分析确定,在任何所研究的病变(n = 34)中均未发现微卫星不稳定性,包括hMLH1表达缺失的导管原位癌。我们得出结论,涉及hMLH1和hMSH2低表达的DNA错配修复缺陷在散发性和家族性乳腺癌中极为罕见。错配修复基因突变可能是乳腺癌进展过程中的继发性随机事件。

相似文献

1
Microsatellite instability in hereditary and sporadic breast cancers.遗传性和散发性乳腺癌中的微卫星不稳定性
Int J Cancer. 2003 Nov 20;107(4):580-2. doi: 10.1002/ijc.11442.
2
Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability.散发性微卫星不稳定型乳腺癌中错配修复基因hMSH2和hMLH1的遗传与表观遗传修饰
Oncogene. 2002 Aug 22;21(37):5696-703. doi: 10.1038/sj.onc.1205683.
3
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.错配修复基因表达缺陷导致卵巢癌中的微卫星不稳定。
Cancer. 2003 Nov 15;98(10):2199-206. doi: 10.1002/cncr.11770.
4
Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.hMSH2和hMSH6表达缺失在伴有微卫星不稳定的散发性子宫内膜癌中很常见:一项基于人群的研究。
Clin Cancer Res. 2002 Jan;8(1):138-43.
5
Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.遗传性非息肉病性结直肠癌和散发性结直肠癌中hMLH1和hMSH2蛋白的免疫组织化学检测
Neoplasma. 2004;51(4):275-84.
6
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.hMLH1和hMSH2的免疫组织化学:DNA错配修复缺陷肿瘤的实用检测方法
Am J Surg Pathol. 1999 Oct;23(10):1248-55. doi: 10.1097/00000478-199910000-00010.
7
BAT-26 microsatellite instability does not correlate with the loss of hMLH1 and hMSH2 protein expression in sporadic endometrial cancers.BAT - 26微卫星不稳定性与散发性子宫内膜癌中hMLH1和hMSH2蛋白表达缺失无关。
Oncol Rep. 2003 Jul-Aug;10(4):1039-43.
8
hMLH1 and hMSH2 expression in human hepatocellular carcinoma.人肝细胞癌中hMLH1和hMSH2的表达
Int J Oncol. 2001 Sep;19(3):567-70.
9
Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes.微卫星不稳定肿瘤中hMSH2和hMLH1的表达改变以及错配修复基因的遗传改变。
Cancer Res. 1996 Nov 1;56(21):4836-40.
10
Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.遗传性非息肉病性结直肠癌和早发性结直肠癌患者错配修复基因hMSH2和hMLH1启动子的突变分析:hMSH2基因启动子中三个新的种系突变的鉴定
Cancer Res. 2002 Jan 1;62(1):38-42.

引用本文的文献

1
Looking beyond the cytogenetics in haematological malignancies: decoding the role of tandem repeats in DNA repair genes.超越血液系统恶性肿瘤的细胞遗传学:解码串联重复在 DNA 修复基因中的作用。
Mol Biol Rep. 2022 Nov;49(11):10293-10305. doi: 10.1007/s11033-022-07761-y. Epub 2022 Sep 12.
2
Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?组织非特异性药物批准:这对乳腺癌患者有何应用?
NPJ Breast Cancer. 2021 Sep 13;7(1):120. doi: 10.1038/s41523-021-00328-3.
3
Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient.
错配修复缺陷通过靶向程序性死亡受体1使一名转移性腔面型乳腺癌患者实现持久完全缓解。
Breast Care (Basel). 2019 Mar;14(1):53-59. doi: 10.1159/000492580. Epub 2018 Nov 14.
4
The Importance of Distinguishing Sporadic Cancers from Those Related to Cancer Predisposing Germline Mutations.区分散发型癌症与与癌症易感种系突变相关癌症的重要性。
Oncologist. 2018 Nov;23(11):1266-1268. doi: 10.1634/theoncologist.2017-0681. Epub 2018 Jun 4.
5
Checkpoint Inhibitors in the Treatment of Breast Cancer.检查点抑制剂在乳腺癌治疗中的应用。
Curr Oncol Rep. 2018 Apr 30;20(7):51. doi: 10.1007/s11912-018-0701-2.
6
Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines.278种广泛使用的肿瘤细胞系的交叉污染和错误鉴定调查
PLoS One. 2017 Jan 20;12(1):e0170384. doi: 10.1371/journal.pone.0170384. eCollection 2017.
7
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.正常风险或高风险乳腺癌女性正常乳腺组织中的基因组变化。
Breast Cancer (Auckl). 2016 Aug 17;10:109-46. doi: 10.4137/BCBCR.S39384. eCollection 2016.
8
The molecular background of mucinous carcinoma beyond MUC2.黏液性癌的分子背景超出 MUC2。
J Pathol Clin Res. 2014 Nov 5;1(1):3-17. doi: 10.1002/cjp2.1. eCollection 2015 Jan.
9
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.错配修复缺陷与免疫检查点阻断反应
Oncologist. 2016 Oct;21(10):1200-1211. doi: 10.1634/theoncologist.2016-0046. Epub 2016 Jul 13.
10
Somatic microsatellite variability as a predictive marker for colorectal cancer and liver cancer progression.体细胞微卫星变异性作为结直肠癌和肝癌进展的预测标志物。
Oncotarget. 2015 Mar 20;6(8):5760-71. doi: 10.18632/oncotarget.3306.